お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
937772

欧州の末梢血管用デバイス市場(2020年~2026年): MedSuite

Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite

出版日: | 発行: iData Research Inc. | ページ情報: 英文 914 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

欧州の末梢血管用デバイス市場(2020年~2026年): MedSuite
出版日: 2020年04月28日
発行: iData Research Inc.
ページ情報: 英文 914 Pages
納期: 即日から翌営業日
担当者のコメント
当サービス(MedSuite)は、セグメント別(MedCore)にご注文可能です。(USD4,995/1セグメント)。まずはサンプル送付させていただきますので、ご希望のセグメントをお知らせください。
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の末梢血管用デバイス市場は、2019年の約13億ユーロから、2026年までに約16億ユーロに達し、予測期間中のCAGRで2.9%の成長が予測されています。

当レポートでは、欧州の末梢血管用デバイス市場について調査分析し、市場分析 (販売数量、ASP、市場金額・成長率の動向) 、市場促進要因・阻害要因、競合分析、最近のM&Aなどについて、体系的な情報を提供しています。

目次

図のリスト

チャートのリスト

エグゼクティブサマリー

末梢血管用デバイスの欧州市場の概要

競合分析

市場動向

市場の発展

処置件数

対象市場

バージョン履歴

調査手法

疾患の概要

  • 基本構造
  • 病気の治療と診断
  • 患者の人口統計

製品ポートフォリオ

  • イントロダクション
  • 製品ポートフォリオ
  • 規制問題とリコール
  • 臨床試験

末梢血管用デバイス市場の概要

  • イントロダクション
    • アテローム性動脈硬化症
    • 末梢動脈疾患(PAD)
  • 為替レート
  • 市場概要
  • 動向分析
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析
  • 企業プロファイル
  • SWOT分析
  • M&A

国別プロファイル

  • イントロダクション
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ベネルクス諸国
  • 北欧諸国
  • オーストリア
  • スイス
  • ポルトガル

処置件数

  • 処置
図表

LIST OF CHARTS

  • Chart 1 1: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 3
  • Chart 1 2: Peripheral Vascular Device Market Overview, Europe, 2016 - 2026 3
  • Chart 4 1: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 179
  • Chart 4 2: Peripheral Vascular Device Market Breakdown, Europe, 2019 180
  • Chart 4 3: Peripheral Vascular Device Market Breakdown, Europe, 2026 181
  • Chart 4 4: Growth Rates by Segment, Peripheral Vascular Device Device Market, Europe, 2016 - 2026 185
  • Chart 4 5: Leading Competitors, Peripheral Vascular Device Market, Europe, 2019 196
  • Chart 5 1: Country Profile, Germany, 2019 229
  • Chart 5 2: Country Profile, France, 2019 230
  • Chart 5 3: Country Profile, United Kingdom, 2019 231
  • Chart 5 4: Country Profile, Italy, 2019 232
  • Chart 5 5: Country Profile, Spain, 2019 233
  • Chart 5 6: Country Profile, Benelux, 2019 234
  • Chart 5 7: Country Profile, Scandinavia, 2019 235
  • Chart 5 8: Country Profile, Austria, 2019 236
  • Chart 5 9: Country Profile, Switzerland, 2019 237
  • Chart 5 10: Country Profile, Portugal, 2019 238
  • Chart 6 1: Bare-Metal Stent Procedures by Segment, Europe, 2016 - 2026 244
  • Chart 7 1: Peripheral Vascular Stent Market by Segment, Europe, 2016 - 2026 303
  • Chart 7 2: Peripheral Vascular Stent Market Breakdown, Europe, 2019 304
  • Chart 7 3: Peripheral Vascular Stent Market Breakdown, Europe, 2026 305
  • Chart 7 4: Peripheral Arterial Stent Market, Europe, 2016 - 2026 308
  • Chart 7 5: Bare-Metal Stent Market by Indication, Europe, 2016 - 2026 316
  • Chart 7 6: Total Bare-Metal Stent Market, Europe, 2016 - 2026 318
  • Chart 7 7: Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 325
  • Chart 7 8: Bare-Metal Femoral-Popliteal Stent Market, Europe, 2016 - 2026 332
  • Chart 7 9: Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 339
  • Chart 7 10: Bare-Metal Renal Stent Market, Europe, 2016 - 2026 346
  • Chart 7 11: Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 353
  • Chart 7 12: Units Sold by Length, Bare-Metal Iliac Stent Market, Europe, 2016 - 2026 360
  • Chart 7 13: Units Sold by Length, Bare-Metal Lower Limb Stent Market, Europe, 2016 - 2026 362
  • Chart 7 14: Units Sold by Length, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 364
  • Chart 7 15: Units Sold by Length, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 366
  • Chart 7 16: Covered Stent Market, Europe, 2016 - 2026 368
  • Chart 7 17: Drug-Eluting Stent Market, Europe, 2016 - 2026 376
  • Chart 7 18: Leading Competitors, Bare-Metal Stent Market, Europe, 2019 389
  • Chart 8 1: Total Peripheral Venous Stent Market, Europe, 2016 - 2026 394
  • Chart 8 2: Leading Competitors, Peripheral Venous Stent Market, Europe, 2019 404
  • Chart 9 1: PTA Balloon Catheter Market by Segment, Europe, 2016 - 2026 410
  • Chart 9 2: PTA Balloon Catheter Market Breakdown, Europe, 2019 411
  • Chart 9 3: PTA Balloon Catheter Market Breakdown, Europe, 2026 412
  • Chart 9 4: Total PTA Balloon Catheter Market, Europe, 2016 - 2026 414
  • Chart 9 5: Standard PTA Balloon Catheter Market, Europe, 2016 - 2026 421
  • Chart 9 6: High-Pressure PTA Balloon Catheter Market, Europe, 2016 - 2026 428
  • Chart 9 7: Large PTA Balloon Catheter Market, Europe, 2016 - 2026 435
  • Chart 9 8: Small PTA Balloon Catheter Market, Europe, 2016 - 2026 442
  • Chart 9 9: Specialty PTA Balloon Catheter Market, Europe, 2016 - 2026 449
  • Chart 9 10: Leading Competitors, PTA Balloon Catheter Market, Europe, 2019 456
  • Chart 10 1: Atherectomy Device Market, Europe, 2016 - 2026 461
  • Chart 10 2: Leading Competitors, Atherectomy Device Market, Europe, 2019 474
  • Chart 11 1: Chronic Total Occlusion Device Market by Segment, Europe, 2016 - 2026 478
  • Chart 11 2: Chronic Total Occlusion Device Market by Segment, Europe, 2019 479
  • Chart 11 3: Chronic Total Occlusion Device Market by Segment, Europe, 2026 480
  • Chart 11 4: Total CTO Device Market, Europe, 2016 - 2026 482
  • Chart 11 5: Recanalization CTO Device Market, Europe, 2016 - 2026 484
  • Chart 11 6: Re-Entry CTO Device Market, Europe, 2016 - 2026 486
  • Chart 11 7: Leading Competitors, Chronic Total Occlusion Device Market, Europe, 2019 491
  • Chart 12 1: Embolic Protection Device Market, Europe, 2016 - 2026 495
  • Chart 12 2: Leading Competitors, Embolic Protection Device Market, Europe, 2019 505
  • Chart 13 1: Stent Graft Market by Segment, Europe, 2016 - 2026 509
  • Chart 13 2: Stent Graft Market Breakdown, Europe, 2019 510
  • Chart 13 3: Stent Graft Market Breakdown, Europe, 2026 511
  • Chart 13 4: Total Stent Graft Market, Europe, 2016 - 2026 514
  • Chart 13 5: AAA Stent Graft Market, Europe, 2016 - 2026 521
  • Chart 13 6: TAA Stent Graft Market, Europe, 2016 - 2026 528
  • Chart 13 7: Fenestrated Stent Graft Market, Europe, 2016 - 2026 536
  • Chart 13 8: Leading Competitors, Stent Graft Market, Europe, 2019 549
  • Chart 14 1: Surgical Graft Market by Segment, Europe, 2016 - 2026 553
  • Chart 14 2: Surgical Graft Market Breakdown, Europe, 2019 554
  • Chart 14 3: Surgical Graft Market Breakdown, Europe, 2026 555
  • Chart 14 4: Total Surgical Graft Market, Europe, 2016 - 2026 557
  • Chart 14 5: Lower Limb Surgical Graft, Europe, 2016 - 2026 564
  • Chart 14 6: AV Access Surgical Graft Market, Europe, 2016 - 2026 571
  • Chart 14 7: Aorta Repair Surgical Graft Market by Segment, Europe, 2016 - 2026 579
  • Chart 14 8: Total Aorta Repair Surgical Graft Market, Europe, 2016 - 2026 581
  • Chart 14 9: AAA Surgical Graft Market, Europe, 2016 - 2026 588
  • Chart 14 10: TAA Surgical Graft Market, Europe, 2016 - 2026 595
  • Chart 14 11: Extra-Anatomical Surgical Graft Market, Europe, 2016 - 2026 602
  • Chart 14 12: Leading Competitors, Surgical Graft Market, Europe, 2019 614
  • Chart 15 1: AV Access Thrombectomy Device Market, Europe, 2016 - 2026 618
  • Chart 15 2: Leading Competitors, AV Access Thrombectomy Device Market, Europe, 2019 628
  • Chart 16 1: Inferior Vena Cava Filter Market, Europe, 2016 - 2026 632
  • Chart 16 2: Leading Competitors, Inferior Vena Cava Filter, Europe, 2019 643
  • Chart 17 1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2016 - 2026 647
  • Chart 17 2: Diagnostic and Interventional Catheter Market Breakdown, Europe, 2019 648
  • Chart 17 3: Diagnostic and Interventional Catheter Market Breakdown, Europe, 2026 649
  • Chart 17 4: Total Diagnostic and Interventional Catheter Market, Europe, 2016 - 2026 651
  • Chart 17 5: Diagnostic Catheter Market, Europe, 2016 - 2026 658
  • Chart 17 6: Interventional Catheter Market, Europe, 2016 - 2026 665
  • Chart 17 7: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2019 677
  • Chart 18 1: Standard and Hydrophilic Guidewire Market by Segment, Europe, 2016 - 2026 681
  • Chart 18 2: Standard and Hydrophilic Guidewire Market Breakdown, Europe, 2019 682
  • Chart 18 3: Standard and Hydrophilic Guidewire Market Breakdown, Europe, 2026 683
  • Chart 18 4: Total Standard and Hydrophilic Guidewire Market, Europe, 2016 - 2026 685
  • Chart 18 5: Standard Guidewire Market, Europe, 2016 - 2026 692
  • Chart 18 6: Hydrophilic Guidewire Graft Market, Europe, 2016 - 2026 699
  • Chart 18 7: Leading Competitors, Standard and Hydrophilic Guidewire Market, Europe, 2019 711
  • Chart 19 1: Introducer Sheath Market, Europe, 2016 - 2026 714
  • Chart 19 2: Leading Competitors, Introducer Sheath Market, Europe, 2019 724
  • Chart 20 1: Vascular Closure Device Market by Segment, Europe, 2016 - 2026 729
  • Chart 20 2: Vascular Closure Device Market Breakdown, Europe, 2019 730
  • Chart 20 3: Vascular Closure Device Market Breakdown, Europe, 2026 731
  • Chart 20 4: Vascular Closure Device Market by Approach, Europe, 2016 - 2026 734
  • Chart 20 5: Vascular Closure Device Market Breakdown, Europe, 2019 735
  • Chart 20 6: Vascular Closure Device Market Breakdown, Europe, 2026 736
  • Chart 20 7: Total Vascular Closure Device Market, Europe, 2016 - 2026 738
  • Chart 20 8: Invasive VCD Market by Device Type, Europe, 2016 - 2026 746
  • Chart 20 9: Invasive VCD Market, Europe, 2016 - 2026 748
  • Chart 20 10: Small Bore Invasive VCD Market, Europe, 2016 - 2026 755
  • Chart 20 11: Large Bore Invasive VCD Market, Europe, 2016 - 2026 763
  • Chart 20 12: Non-Invasive VCD Market, Europe, 2016 - 2026 770

Chart 20 13 Vascular Closure Device Market by Approach, Europe, 2016 - 2026 777

  • Chart 20 14: Femoral VCD Market, Europe, 2016 - 2026 779
  • Chart 20 15: Radial VCD Market, Europe, 2016 - 2026 786
  • Chart 20 16: Leading Competitors, VCD Market, Europe, 2019 798
  • Chart 21 1: Transcatheter Embolization Device Market by Segment, Europe, 2016 - 2026 804
  • Chart 21 2: Transcatheter Embolization Device Market Breakdown, Europe, 2019 805
  • Chart 21 3: Transcatheter Embolization Device Market Breakdown, Europe, 2026 806
  • Chart 21 4: Particle Embolic Device Market, Europe, 2016 - 2026 810
  • Chart 21 5: Coil Embolic Device Market, Europe, 2016 - 2026 818
  • Chart 21 6: Liquid Embolic Device Market, Europe, 2016 - 2026 825
  • Chart 21 7: Leading Competitors, Transcatheter Embolization Device Market, Europe, 2019 838
  • Chart 22 1: Drug-Coated Balloon Catheter Market, Europe, 2016 - 2026 842
  • Chart 23 1: Intravascular Lithotripsy Market, U.S., 2016 - 2026 852
  • Chart 24 1: Peripheral IVUS Catheter Market, U.S., 2016 - 2026 859
  • Chart 24 2: Leading Competitors, Peripheral IVUS Catheter Market, Europe, 2019 865

LIST OF FIGURES

  • Figure 1 1: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (1 of 4) 4
  • Figure 1 2: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (2 of 4) 5
  • Figure 1 3: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (3 of 4) 5
  • Figure 1 4: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (4 of 4) 5
  • Figure 1 5: Companies Researched in this Report, Europe, 2019 (1 of 2) 7
  • Figure 1 6: Companies Researched in this Report, Europe, 2019 (2 of 2) 8
  • Figure 1 7: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (1 of 4) 9
  • Figure 1 8: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (2 of 4) 10
  • Figure 1 9: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (3 of 4) 11
  • Figure 1 10: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (4 of 4) 12
  • Figure 1 11: Recent Events in the Peripheral Vascular Device Market, European, 2016 - 2019 13
  • Figure 1 12: Peripheral Vascular Procedures Covered, Europe, 2019 (1 of 2) 14
  • Figure 1 13: Peripheral Vascular Procedures Covered, Europe, 2019 (2 of 2) 15
  • Figure 1 14: Peripheral Vascular Device Markets Covered, Europe, 2019 (1 of 2) 16
  • Figure 1 15: Peripheral Vascular Device Markets Covered, Europe, 2019 (2 of 2) 17
  • Figure 1 16: Version History 18
  • Figure 3 1: Peripheral Vascular Stent by Company (1 of 2) 44
  • Figure 3 2: Peripheral Vascular Stent by Company (2 of 2) 45
  • Figure 3 3: Venous Stent by Company 46
  • Figure 3 4: PTA Balloon Catheter by Company (1 of 3) 48
  • Figure 3 5: PTA Balloon Catheter by Company (2 of 3) 49
  • Figure 3 6: PTA Balloon Catheter by Company (3 of 3) 50
  • Figure 3 7: Drug-Coated Balloon by Company 52
  • Figure 3 8: Atherectomy Device by Company 54
  • Figure 3 9: Chronic Total Occlusion Device by Company 56
  • Figure 3 10: Lithotripsy Device by Company 57
  • Figure 3 11: Surgical Graft by Company (1 of 2) 59
  • Figure 3 12: Surgical Graft by Company (2 of 2) 60
  • Figure 3 13: Stent Graft by Company 62
  • Figure 3 14: Embolic Protection Device by Company 64
  • Figure 3 15: Peripheral Thrombus Management by Company 67
  • Figure 3 16: Inferior Vena Cava Filter by Company 68
  • Figure 3 17: Carotid Shunt by Company 69
  • Figure 3 18: Diagnostic and Interventional Catheters by Company (1 of 2) 71
  • Figure 3 19: Diagnostic and Interventional Catheters by Company (2 of 2) 71
  • Figure 3 20: Diagnostic and Interventional Guidewire by Company (1 of 3) 74
  • Figure 3 21: Diagnostic and Interventional Guidewire by Company (2 of 3) 74
  • Figure 3 22: Diagnostic and Interventional Guidewire by Company (3 of 3) 76
  • Figure 3 23: Introducer Sheath by Company (1 of 4) 77
  • Figure 3 24: Introducer Sheath by Company (2 of 4) 78
  • Figure 3 25: Introducer Sheath by Company (3 of 4) 79
  • Figure 3 26: Introducer Sheath by Company (4 of 4) 80
  • Figure 3 27: Vascular Closure Device by Company (1 of 2) 81
  • Figure 3 28: Vascular Closure Device by Company (2 of 2) 82
  • Figure 3 29: Transcatheter Embolization Devices by Company (1 of 2) 84
  • Figure 3 30: Transcatheter Embolization Devices by Company (2 of 2) 85
  • Figure 3 31: Peripheral IVUS Catheter by Company 86
  • Figure 3 32: Class 2 Device Recall RX ACCULINK Carotid Stent System 87
  • Figure 3 33: Class 2 Device Recall StarClose SE Vascular Closure System, Abbot 87
  • Figure 3 34: Class 2 Device Recall ClosureFast Micro Introducer Sheath Set, Argon Medical 88
  • Figure 3 35: Class 2 Device Recall Super ArrowFlex Percutaneous Sheath Introducer Sets, Arrow 88
  • Figure 3 36: Class 2 Device Recall Percutaneous Sheath Introducer Kit, Arrow 89
  • Figure 3 37: Class 2 Device Recall Super ArrowFlex(R) Percutaneous Sheath Introducer Set with Integral Hemostasis Valve/Side Port, Arrow 89
  • Figure 3 38: Class 2 Device Recall Arrow 89
  • Figure 3 39: Class 2 Device Recall Arrow Percutaneous Sheath Introducer Kits, Arrow 90
  • Figure 3 40: Class 2 Device Recall iCAST and Advanta 91
  • Figure 3 41: Class 2 Device Recall Denali Filter Femoral Delivery System, Bard Peripheral Vascular Inc 92
  • Figure 3 42: Class 2 Device Recall Denali Filter Jugular Subclavian Delivery System, Bard Peripheral Vascular Inc 92
  • Figure 3 43: Class 1 Device Recall Bard Peripheral Vascular 92
  • Figure 3 44: Class 2 Device Recall FLAIR Endovascular Stent Graft, Bard Peripheral Vascular Inc 93
  • Figure 3 45: Class 2 Device Recall, Boston Scientific 94
  • Figure 3 46: Class 1 Device Recall Boston Scientific 94
  • Figure 3 47: Class 2 Device Recall Boston Scientific Imager II Angiographic Catheter 95
  • Figure 3 48: Class 2 Device Recall IMAGER II Angiographic Catheters 95
  • Figure 3 49: Class 2 Device Recall Guider Softip XF 95
  • Figure 3 50: Class 1 Device Recall Boston Scientific 96
  • Figure 3 51: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath 96
  • Figure 3 52: Class 1 Device Recall Chariot" Guiding Sheath 96
  • Figure 3 53: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific 97
  • Figure 3 54: Class 2 Device Recall AngioJet Thrombectomy Set, Boston Scientific 97
  • Figure 3 55: Class 2 Device Recall Cardinal Health 98
  • Figure 3 56: Class 2 Device Recall ViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Cardiovascular Systems Inc 99
  • Figure 3 57: Class 2 Device Recall ViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Cardiovascular Systems Inc 99
  • Figure 3 58: Class 2 Device Recall DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Cardiovascular Systems Inc 99
  • Figure 3 59: Class 2 Device Recall ViperWire Advance peripheral guide wire, Cardiovascular Systems Inc 100
  • Figure 3 60: Class 1 Device Recall Diamondback 360 Peripheral Orbital Atherectomy System 100
  • Figure 3 61: Class 2 Device Recall SlipCath Beacon Tip Catheter 101
  • Figure 3 62: Class 2 Device Recall CheckFlo Performer Introducer Set 101
  • Figure 3 63: Class 2 Device Recall Micropuncture CheckFlo Performer Introducer Set 101
  • Figure 3 64: Class 2 Device Recall CheckFlo Introducer HausdorfLock Atrial 102
  • Figure 3 65: Class 3 Device Recall Gunther Tulip Vena Cava Filter Set 102
  • Figure 3 66: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set 102
  • Figure 3 67: Class 2 Device Recall Cook Medical 103
  • Figure 3 68: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft 103
  • Figure 3 69: Class 1 Device Recall Zenith Alpha Thoracic Endovascular Graft 103
  • Figure 3 70: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter 104
  • Figure 3 71: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter 104
  • Figure 3 72: Class 1 Device Recall OptEase Vena Cava Filter, Cordis 104
  • Figure 3 73: Class 2 Device Recall Cordis S.M.A.R.T. Flex Vascular Stent System 105
  • Figure 3 74: Class 2 Device Recall Transhepatic Biliary Stent System 105
  • Figure 3 75: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System 106
  • Figure 3 76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft 106
  • Figure 3 77: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System 106
  • Figure 3 78: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft 106
  • Figure 3 79: Class 2 Device Recall AFX Endovascular AAA System, Endologix 107
  • Figure 3 80: Class 1 Device Recall IntraClude IntraAortic Occlusion Device 108
  • Figure 3 81: Class 2 Device Recall IntraClude(TM) IntraAortic Occlusion Device 108
  • Figure 3 82: Class 2 Device Recall Edwards Lifesciences IntraClude IntraAortic Occlusion Device 108
  • Figure 3 83: Class 2 Device Recall Corkscrew Catheter 108
  • Figure 3 84: Class 1 Device Recall CS100 IntraAortic Balloon Pump 109
  • Figure 3 85: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump 109
  • Figure 3 86: Class 1 Device Recall Cardiosave Hybrid IABP 109
  • Figure 3 87: Class 2 Device Recall Protege Rx Tapered Carotid Stent System, Eve Inc. 110
  • Figure 3 88: Class 1 Device Recall Covidien 110
  • Figure 3 89: Class 2 Device Recall PowerCross .018 OTW PTA Dilation Catheter, Medtronic 110
  • Figure 3 90: Class 2 Device Recall Ev3, Inc. (Medtronic) 111
  • Figure 3 91: Class 2 Device Recall Amphirion Deep OTW PTA Balloon Catheter, Medtronic 111
  • Figure 3 92: lass 2 Device Recall EV3 EverFiex" Selfexpanding Peripheral Stent System, Ev3 Inc. 112
  • Figure 3 93: Class 2 Device Recall Medtronic Aptus™ HeliFX™ Thoracic EndoAnchor™ System HeliFX Guide 42 mm, Medtronic 112
  • Figure 3 94: Class 2 Device Recall Endurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems, Medtronic 112
  • Figure 3 95: Class 2 Device Recall FIBERNET Embolic Protection System, Medtronic 113
  • Figure 3 96: Class 2 Device Recall Spectranetics TurboElite Laser Atherectomy Catheters, Spectranetics 114
  • Figure 3 97: Class 2 Device Recall Turbo Elite Atherectomy Catheter, Spectranetics 114
  • Figure 3 98: Class 2 Device Recall TurboPower, Spectranetics 114
  • Figure 3 99: Class 1 Device Recall Bridge Balloon Catheter 115
  • Figure 3 100: Class 1 Device Recall Bridge Balloon 115
  • Figure 3 101: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System 116
  • Figure 3 102: Class 2 Device Recall PINNACLE Introducer Sheath, Terumo 117
  • Figure 3 103: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System 117
  • Figure 3 104: Class 2 Device Recall DIAMONDBACK 360 Peripheral Orbital Atherectomy System 117
  • Figure 3 105: Class 1 Device Recall 7F Prelude Short Sheath Introducer, Merit 118
  • Figure 3 106: Class 2 Device Recall USE PTA 0.014 RX Catheter, Us Endovascular 118
  • Figure 3 107: Class 2 Device Recall Balloon Catheter, EXP Pharmaceutical Services Corp 118
  • Figure 3 108: Class 2 Device Recall IVUS Catheter, Volcano 119
  • Figure 3 109: Class 1 Device Recall Ovation Prime Abdominal Stent Graft System, TriVascular 119
  • Figure 3 110: Class 2 Device Recall Ovation Prime Abdominal Stent Graft System, TriVascular 119
  • Figure 3 111: Class 2 Device Recall MynxGrip Vascular Closure Device 120
  • Figure 3 112: Class 2 Device Recall Vascular closure device, EXP Pharmaceutical (OEM) 120
  • Figure 3 113: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease 121
  • Figure 3 114: Stella Supera Siberia 121
  • Figure 3 115: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease 122
  • Figure 3 116: Absolute Pro® MOMENTUM™ (MOMENTUM) 122
  • Figure 3 117: Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery (SUPERB) 123
  • Figure 3 118: Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery (MOBILITY OE) 123
  • Figure 3 119: Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. (MOBILITY AP) 124
  • Figure 3 120: ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System 124
  • Figure 3 121: Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW) 125
  • Figure 3 122: "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended) 125
  • Figure 3 123: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II) 126
  • Figure 3 124: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME) 126
  • Figure 3 125: The Jetstream (JET) Post-market Registry (JET) 127
  • Figure 3 126: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA) 127
  • Figure 3 127: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease 128
  • Figure 3 128: An Efficacy and Safety Study to Evaluate Ranger DEB 128
  • Figure 3 129: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery 129
  • Figure 3 130: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL) 129
  • Figure 3 131: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME) 130
  • Figure 3 132: VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction (VIRTUS) 130
  • Figure 3 133: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon 131
  • Figure 3 134: Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) 131
  • Figure 3 135: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB) 132
  • Figure 3 136: Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon 132
  • Figure 3 137: Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB 133
  • Figure 3 138: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR) 133
  • Figure 3 139: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon 134
  • Figure 3 140: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME) 134
  • Figure 3 141: The Safety and Efficacy of an Extravascular, Water-Soluble Sealant 135
  • Figure 3 142: Zilver® PTX® V Clinical Study 136
  • Figure 3 143: Zilver Flex Post-Market Study in Japan 136
  • Figure 3 144: Zilver PTX Post-Market Study in Japan 136
  • Figure 3 145: Zilver® PTX® in China 137
  • Figure 3 146: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) 137
  • Figure 3 147: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE) 138
  • Figure 3 148: FORMAT Clinical Study 138
  • Figure 3 149: VIVO Clinical Study 139
  • Figure 3 150: Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion 140
  • Figure 3 151: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN) 140
  • Figure 3 152: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon 141
  • Figure 3 153: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) 141
  • Figure 3 154: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT) 142
  • Figure 3 155: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB (FORTEZ) 142
  • Figure 3 156: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA 143
  • Figure 3 157: IN.PACT Global Clinical Study 143
  • Figure 3 158: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease 144
  • Figure 3 159: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) 144
  • Figure 3 160: Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis (INTACT) 145
  • Figure 3 161: Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study) 145
  • Figure 3 162: In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions (INPCTFLEXION) 146
  • Figure 3 163: IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) (INPACT SFA II) 146
  • Figure 3 164: Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia (INPACT-DEEP) 147
  • Figure 3 165: Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease (INPACT SFA I) 147
  • Figure 3 166: The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population 148
  • Figure 3 167: EverFlex Post Approval Study (DURABILITY PAS) 148
  • Figure 3 168: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME) 149
  • Figure 3 169: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease 150
  • Figure 3 170: Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI (REACH PVI) 151
  • Figure 3 171: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) 151
  • Figure 3 172: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS) 152
  • Figure 3 173: TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions 152
  • Figure 3 174: ILLUMENATE Pivotal Post-Approval Study (PAS) 153
  • Figure 3 175: Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon (ILLUMENATE) 153
  • Figure 3 176: Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis (INTACT) 154
  • Figure 3 177: Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions (ILLUMENATE) 154
  • Figure 3 178: An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies (REX) 155
  • Figure 3 179: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) 156
  • Figure 3 180: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND) 157
  • Figure 3 181: Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon (PREVEIL) 157
  • Figure 3 182: Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon (KANSHAS1) 158
  • Figure 3 183: Misago® RX Self-Expanding Peripheral Stent 158
  • Figure 3 184: In-Stent Restenosis Post-Approval Study 159
  • Figure 3 185: Evaluation of the GORE TIGRIS Vascular Stent (TIGRIS) 159
  • Figure 3 186: A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. (VBXFLEX) 160
  • Figure 3 187: Multi-center Study for Stent Graft System for Peripheral Artery (VJH 11-01) 160
  • Figure 3 188: Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels (EXPAND) 161
  • Figure 3 189: " Endarterectomy Combined With Optimal Medical Therapy (OMT) vs OMT Alone in Patients With Asymptomatic Severe Atherosclerotic Carotid Artery Stenosis at Higher-than-average Risk of Ipsilateral Stroke " (ACTRIS) 162
  • Figure 3 190: Carotid Endarterectomy and Carotid Artery Stenting in Brazil 162
  • Figure 3 191: Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease 163
  • Figure 3 192: Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty (FAVABED) 163
  • Figure 3 193: BIOLUX P-III BENELUX All-Comers Registry 164
  • Figure 3 194: BIOLUX P-III SPAIN All-Comers Registry 164
  • Figure 3 195: Drug Eluting Balloon for Early Fistula Failure Trial (DEBEFF) 164
  • Figure 3 196: Drug-Eluting Balloon in Arteriovenous Graft 165
  • Figure 3 197: Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions (ADCAT) 165
  • Figure 3 198: Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial (ENDURE) 165
  • Figure 3 199: AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China 166
  • Figure 3 200: AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China 166
  • Figure 3 201: Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (DRECOREST1) 167
  • Figure 3 202: Stella Supera Siberia 167
  • Figure 3 203: Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU) 168
  • Figure 3 204: Clinical Study of Passeo-18 Lux Balloon Catheter for the Treatment of Atherosclerotic Lesions(BIOLUX-P IV CHINA) 168
  • Figure 3 205: Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents (BIOFLEX-I) 168
  • Figure 3 206: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN) 169
  • Figure 3 207: Remedy, Biodegradable Peripheral Stent Registry 169
  • Figure 3 208: BIOLUX P-III All-Comers Passeo-18 Lux Registry 170
  • Figure 3 209: BIOTRONIK 4French for AMBulatory Peripheral Intervention (BIO4AMB) 170
  • Figure 4 1: Currency Exchange Rate, 2019 173
  • Figure 4 2: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (€M) (1 of 2) 175
  • Figure 4 3: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (€M) (2 of 2) 176
  • Figure 4 4: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (US$M) (1 of 2) 177
  • Figure 4 5: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (US$M) (2 of 2) 178
  • Figure 4 6: Growth Rates by Segment, Peripheral Vascular Device Market, Europe, 2016 - 2026 (1 of 2) 183
  • Figure 4 7: Growth Rates by Segment, Peripheral Vascular Device Market, Europe, 2016 - 2026 (2 of 2) 184
  • Figure 4 8: Drivers and Limiters, Peripheral Vascular Device Market, Europe, 2019 188
  • Figure 4 9: Leading Competitors, Peripheral Vascular Device Market, Europe, 2019 (1 of 2) 194
  • Figure 4 10: Leading Competitors, Peripheral Vascular Device Market, Europe, 2019 (2 of 2) 195
  • Figure 4 11: SWOT Analysis, Abbott 209
  • Figure 4 12: SWOT Analysis, B. Braun 210
  • Figure 4 13: SWOT Analysis, Boston Scientific 211
  • Figure 4 14: SWOT Analysis, Cardinal Health 213
  • Figure 4 15: SWOT Analysis, Cook Medical 214
  • Figure 4 16: SWOT Analysis, Integra Lifesciences 215
  • Figure 4 17: SWOT Analysis, Maquet 216
  • Figure 4 18: SWOT Analysis, Medtronic 217
  • Figure 4 19: SWOT Analysis, Merit Medical 218
  • Figure 4 20: SWOT Analysis, Phillips 219
  • Figure 4 21: SWOT Analysis, Teleflex 220
  • Figure 4 22: SWOT Analysis, Terumo 221
  • Figure 4 23: SWOT Analysis, W.L. Gore 222
  • Figure 6 1: Total Peripheral Vascular Procedures by Country, Europe, 2016 - 2026 240
  • Figure 6 2: Total Bare Metal Stent Procedures by Country, Europe, 2016 - 2026 242
  • Figure 6 3: Total Bare Metal Stent Procedures by Indication, Europe, 2016 - 2026 243
  • Figure 6 4: Mean Number of Bare Metal Stents Used Per Procedure by Indication, Europe, 2016 - 2026 245
  • Figure 6 5: Iliac Bare Metal Stent Procedures by Country, Europe, 2016 - 2026 246
  • Figure 6 6: Femoral Popliteal Bare Metal Stent Procedures by Country, Europe, 2016 - 2026 247
  • Figure 6 7: Infra-Popliteal Bare Metal Stent Procedures by Country, Europe, 2016 - 2026 248
  • Figure 6 8: Renal Bare Metal Stent Procedures by Country, Europe, 2016 - 2026 249
  • Figure 6 9: Carotid Bare Metal Stent Procedures by Country, Europe, 2016 - 2026 250
  • Figure 6 10: Mean Number of Venous Stents Used Per Procedure, Europe, 2016 - 2026 251
  • Figure 6 11: Venous Stenting Procedures by Country, Europe, 2016 - 2026 252
  • Figure 6 12: Mean Number of PTA Balloons Used Per Procedure, Europe, 2016 - 2026 253
  • Figure 6 13: Angioplasty Procedures by Country, Europe, 2016 - 2026 254
  • Figure 6 14: Mean Number of Atherectomy Devices Used Per Procedure, Europe, 2016 - 2026 255
  • Figure 6 15: Atherectomy Procedures by Country, Europe, 2016 - 2026 256
  • Figure 6 16: CTO Device Procedures, Europe, 2016 - 2026 257
  • Figure 6 17: Mean Number of CTO Devices Used Per Procedure, Europe, 2016 - 2026 257
  • Figure 6 18: Mean Number of Embolic Protection Devices Used Per Procedure, Europe, 2016 - 2026 258
  • Figure 6 19: Embolic Protection Device Procedures by Country, Europe, 2016 - 2026 259
  • Figure 6 20: Total Stent Graft Procedures by Country, Europe, 2016 - 2026 260
  • Figure 6 21: AAA Stent Graft Procedures by Country, Europe, 2016 - 2026 261
  • Figure 6 22: TAA Stent Graft Procedures by Country, Europe, 2016 - 2026 262
  • Figure 6 23: Fenestrated Stent Graft Procedures by Country, Europe, 2016 - 2026 263
  • Figure 6 24: Total Surgical Graft Procedures by Country, Europe, 2016 - 2026 264
  • Figure 6 25: Lower Limb Surgical Graft Procedures by Country, Europe, 2016 - 2026 265
  • Figure 6 26: AV Access Surgical Graft Procedures by Country, Europe, 2016 - 2026 266
  • Figure 6 27: Mean Number of Aorta Repair Surgical Grafts Used Per Procedure, Europe, 2016 - 2026 267
  • Figure 6 28: Aorta Repair Surgical Graft Procedures by Country, Europe, 2016 - 2026 268
  • Figure 6 29: AAA Surgical Graft Procedures by Country, Europe, 2016 - 2026 269
  • Figure 6 30: TAA Surgical Graft Procedures by Country, Europe, 2016 - 2026 270
  • Figure 6 31: Extra-Anatomical Surgical Graft Procedures by Country, Europe, 2016 - 2026 271
  • Figure 6 32: Mean Number of Thrombectomy Devices Used Per Procedure, Europe, 2016 - 2026 272
  • Figure 6 33: AV Access Thrombectomy Procedures by Country, Europe, 2016 - 2026 273
  • Figure 6 34: Mean Number of Inferior Vena Cava Filter Used Per Procedure, Europe, 2016 - 2026 274
  • Figure 6 35: Inferior Vena Cava Filter Procedures by Country, Europe, 2016 - 2026 275
  • Figure 6 36: Mean Number of Vascular Closure Devices Used Per Procedure, Europe, 2016 - 2026 276
  • Figure 6 37: Total Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 277
  • Figure 6 38: Total Invasive Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 278
  • Figure 6 39: Mean Number of Invasive Vascular Closure Devices Used Per Procedure, Europe, 2016 - 2026 279
  • Figure 6 40: Invasive Small Bore Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 280
  • Figure 6 41: Invasive Large Bore Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 281
  • Figure 6 42: Non-Invasive Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 282
  • Figure 6 43: Mean Number of Vascular Closure Devices Used Per Procedure by Approach, Europe, 2016 - 2026 283
  • Figure 6 44: Femoral Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 284
  • Figure 6 45: Radial Vascular Closure Device Procedures by Country, Europe, 2016 - 2026 285
  • Figure 6 46: Mean Number of Embolization Devices Used Per Procedure, Europe, 2016 - 2026 286
  • Figure 6 47: Total Transcatheter Embolization Procedures by Country, Europe, 2016 - 2026 287
  • Figure 6 48: Particle Embolization Procedures by Country, Europe, 2016 - 2026 288
  • Figure 6 49: Coil Embolization Procedures by Country, Europe, 2016 - 2026 289
  • Figure 6 50: Liquid Embolization Procedures by Country, Europe, 2016 - 2026 290
  • Figure 6 51: Mean Number of Drug-Coated Balloons Per Procedure, Europe, 2016 - 2026 291
  • Figure 6 52: Drug-Coated Balloon Procedures by Country, Europe, 2016 - 2026 292
  • Figure 6 53: Mean Number of Lithotripsy Balloons Catheters Per Procedure, Europe, 2016 - 2026 293
  • Figure 6 54: Lithotripsy Procedures, Europe, 2016 - 2026 293
  • Figure 6 55: Mean Number of IVUS Catheters Per Procedure, Europe, 2016 - 2026 294
  • Figure 6 56: IVUS Procedures, Europe, 2016 - 2026 294
  • Figure 7 1: Stent Properties by Indication, Peripheral Vascular Stent Market, Europe, 2019 299
  • Figure 7 2: Stents Used per Procedure by Indication, Europe, 2019 299
  • Figure 7 3: Peripheral Vascular Stent Market by Segment, Europe, 2016 - 2026 (€M) 301
  • Figure 7 4: Peripheral Vascular Stent Market by Segment, Europe, 2016 - 2026 (US$M) 302
  • Figure 7 5: Peripheral Arterial Stent Market, Europe, 2016 - 2026 (€ and US$) 307
  • Figure 7 6: Units Sold by Country, Total Peripheral Vascular Stent Device Market, Europe, 2016 - 2026 309
  • Figure 7 7: Average Selling Price by Country, Total Peripheral Vascular Stent Market, Europe, 2016 - 2026 (€) 310
  • Figure 7 8: Average Selling Price by Country, Total Peripheral Vascular Stent Market, Europe, 2016 - 2026 (US$) 311
  • Figure 7 9: Market Value by Country, Peripheral Vascular Stent Market, Europe, 2016 - 2026 (€M) 312
  • Figure 7 10: Market Value by Country, Peripheral Vascular Stent Market, Europe, 2016 - 2026 (US$M) 313
  • Figure 7 11: Bare-Metal Stent Market by Indication Europe, 2016 - 2026 (€M) 315
  • Figure 7 12: Total Bare-Metal Stent, Europe, 2016 - 2026 (€M) 317
  • Figure 7 13: Units Sold by Country, Total Bare-Metal Stent Market, Europe, 2016 - 2026 319
  • Figure 7 14: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2016 - 2026 (€) 320
  • Figure 7 15: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2016 - 2026 (US$) 321
  • Figure 7 16: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2016 - 2026 (€M) 322
  • Figure 7 17: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2016 - 2026 (US$M) 323
  • Figure 7 18: Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 (€ and US$) 324
  • Figure 7 19: Units Sold by Country, Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 326
  • Figure 7 20: Average Selling Price by Country, Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 (€) 327
  • Figure 7 21: Average Selling Price by Country, Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 (US$) 328
  • Figure 7 22: Market Value by Country, Bare-Metal Illiac Stent Device Market, Europe, 2016 - 2026 (€M) 329
  • Figure 7 23: Market Value by Country, Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 (US$M) 330
  • Figure 7 24: Bare-Metal Femoral-Popliteal Stent Market, Europe, 2016 - 2026 (€ and US$) 331
  • Figure 7 25: Units Sold by Country, Bare-Metal Femoral-Popliteal Stent Market, Europe, 2016 - 2026 333
  • Figure 7 26: Average Selling Price by Country, Bare-Metal Femoral-Popliteal Stent Market, Europe, 2016 - 2026 (€) 334
  • Figure 7 27: Average Selling Price by Country, Bare-Metal Femoral-Popliteal Stent Market, Europe, 2016 - 2026 (US$) 335
  • Figure 7 28: Bare-Metal Femoral-Popliteal Stent Market by Country, Europe, 2016 - 2026 (€M) 336
  • Figure 7 29: Bare-Metal Femoral-Popliteal Stent Market by Country, Europe, 2016 - 2026 (US$M) 337
  • Figure 7 30: Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 (€ and US$) 338
  • Figure 7 31: Units Sold by Country, Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 340
  • Figure 7 32: Average Selling Price by Country, Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 (€) 341
  • Figure 7 33: Average Selling Price by Country, Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 (US$) 342
  • Figure 7 34: Market Value by Country, Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 (€M) 343
  • Figure 7 35: Market Value by Country, Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 (US$M) 344
  • Figure 7 36: Bare-Metal Renal Stent Market, Europe, 2016 - 2026 (€ and US$) 345
  • Figure 7 37: Units Sold by Country, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 347
  • Figure 7 38: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 (€) 348
  • Figure 7 39: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 (US$) 349
  • Figure 7 40: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 (€M) 350
  • Figure 7 41: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 (US$M) 351
  • Figure 7 42: Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 (€ and US$) 352
  • Figure 7 43: Units Sold by Country, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 354
  • Figure 7 44: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 (€) 355
  • Figure 7 45: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 (US$) 356
  • Figure 7 46: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 (€M) 357
  • Figure 7 47: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 (US$M) 358
  • Figure 7 48: Units Sold by Length, Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 359
  • Figure 7 49: Units Sold by Length, Bare-Metal Lower Limb Stent Market, Europe, 2016 - 2026 361
  • Figure 7 50: Units Sold by Length, Bare-Metal Renal Limb Stent Market, Europe, 2016 - 2026 363
  • Figure 7 51: Units Sold by Length, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 365
  • Figure 7 52: Covered Stent Market, Europe, 2016 - 2026 (€ and US$) 367
  • Figure 7 53: Units Sold by Country, Covered Stent Market, Europe, 2016 - 2026 369
  • Figure 7 54: Average Selling Price by Country, Covered Stent Market, Europe, 2016 - 2026 (€) 370
  • Figure 7 55: Average Selling Price by Country, Covered Stent Market, Europe, 2016 - 2026 (US$) 371
  • Figure 7 56: Covered Stent Market by Country, Europe, 2016 - 2026 (€M) 372
  • Figure 7 57: Covered Stent Market by Country, Europe, 2016 - 2026 (US$M) 373
  • Figure 7 58: Drug-Eluting Stent Market, Europe, 2
目次
Product Code: iDATA_EUPV20_MS

The European peripheral vascular device market was valued at about €1.3 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.9% to reach about €1.6 billion by 2026.

The growth of venous treatments in Europe is expected to accelerate in the coming years as clinical knowledge continues to develop and expertise in the medical community is diffused. While currently consolidated within select regions in the United Kingdom, Germany, France, Austria and Switzerland, venous treatment centers are expected to be developed across Europe to facilitate both the diagnosis and treatment of venous disease.

Treatment of peripheral arterial disease is slowly continuing to increase its penetration in the treatable population. As Europe continues to age, the total number of procedures is expected to

grow over the forecast period. As reimbursement tensions continue, treatment techniques have continued to be refined towards the most cost effective, long-term option for patients.

The full report suite on the European market for peripheral vascular (PV) devices includes peripheral arterial stents, peripheral venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. There is also a series of appendices containing analyses on drug-coated balloons (DCBs), lithotripsy balloon catheters and peripheral intravascular ultrasound (IVUS) catheters.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR PERIPHERAL VASCULAR DEVICES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 BASIC ANATOMY
  • 2.2 DISEASE TREATMENTS & DIAGNOSTICS
    • 2.2.1 Aortic Aneurysms
    • 2.2.2 Atherosclerosis
    • 2.2.3 Peripheral Arterial Disease (PAD)
    • 2.2.4 Deep Vein Thrombosis (DVT)
    • 2.2.5 Pulmonary Embolism (PE)
  • 2.3 PATIENT DEMOGRAPHICS
    • 2.3.1 Aortic Aneurysms
    • 2.3.2 Atherosclerosis
    • 2.3.3 Peripheral Arterial Disease (PAD)
    • 2.3.4 Deep Vein Thrombosis (DVT)
    • 2.3.5 Pulmonary Embolism (PE)

PRODUCT PORTFOLIO

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS
    • 3.2.1 Peripheral Vascular Stent
    • 3.2.2 Venous Stent
    • 3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon
    • 3.2.4 Drug-Coated Balloon
    • 3.2.5 Atherectomy Device
    • 3.2.6 Chronic Total Occlusion (CTO) Device
    • 3.2.7 Intravascular Lithotripsy
    • 3.2.8 Surgical Graft
    • 3.2.9 Stent Graft
    • 3.2.10 Embolic Protection Device
    • 3.2.11 Peripheral Thrombus Management Device
    • 3.2.12 Inferior Vena Cava Filter
    • 3.2.13 Carotid Shunt
    • 3.2.14 Diagnostic and Interventional Catheters
    • 3.2.15 Diagnostic and Interventional Guidewire
    • 3.2.16 Introducer Sheath
    • 3.2.17 Vascular Closure Device (VCD)
    • 3.2.18 Transcatheter Embolization Device
    • 3.2.19 Peripheral IVUS Catheter
  • 3.3 REGULATORY ISSUES AND RECALLS
    • 3.3.1 Abbott
      • 3.3.1.1 Carotid Shunt
      • 3.3.1.2 Vascular Closure Device
    • 3.3.2 Argon Medical
      • 3.3.2.1 Introducer Sheaths
    • 3.3.3 Arrow International
      • 3.3.3.1 Introducer Sheaths
    • 3.3.4 Atrium Medical
      • 3.3.4.1 Peripheral Vascular Stent
    • 3.3.5 BD
      • 3.3.5.1 Inferior Vena Cava Filter
      • 3.3.5.2 Introducer Sheaths
      • 3.3.5.3 Stent Graft
    • 3.3.6 Boston Scientific
      • 3.3.6.1 Atherectomy Devices
      • 3.3.6.2 Diagnostic and Interventional Catheters
      • 3.3.6.3 Introducer Sheaths
      • 3.3.6.4 Peripheral Thrombus Management Devices
    • 3.3.7 Cardinal Health
      • 3.3.7.1 Vascular Closure Devices
    • 3.3.8 Cardiovascular System (C.S.I.)
      • 3.3.8.1 Atherectomy Devices
    • 3.3.9 Cook Medical
      • 3.3.9.1 Diagnostic and Interventional Catheters
      • 3.3.9.2 Introducer Sheaths
      • 3.3.9.3 Inferior Vena Cava Filters
      • 3.3.9.4 Peripheral Vascular Stents
      • 3.3.9.5 Stent Grafts
    • 3.3.10 Cordis (Cardinal Health)
      • 3.3.10.1 Diagnostic and Interventional Catheters
      • 3.3.10.2 Inferior Vena Cava Filters
      • 3.3.10.3 Peripheral Stents
    • 3.3.11 Endologix
      • 3.3.11.1 Stent Grafts
    • 3.3.12 Edwards Lifesciences
      • 3.3.12.1 Chronic Total Occlusion Devices
    • 3.3.13 Maquet
      • 3.3.13.1 PTA Balloons
    • 3.3.14 Medtronic
      • 3.3.14.1 Carotid Shunts
      • 3.3.14.2 Diagnostic and Interventional Catheters
      • 3.3.14.3 PTA Balloon Catheters
      • 3.3.14.4 Peripheral Stents
      • 3.3.14.5 Stent Grafts
      • 3.3.14.6 Transcatheter Embolization Devices
    • 3.3.15 Spectranetics (Philips)
      • 3.3.15.1 Atherectomy Devices
      • 3.3.15.2 Chronic Total Occlusion Devices
    • 3.3.16 Shockwave Medical, Inc.
      • 3.3.16.1 Intravascular Lithotripsy
    • 3.3.17 Terumo
      • 3.3.17.1 Introducer Sheaths
      • 3.3.17.2 PTA Balloon Catheters
    • 3.3.18 Other Companies
      • 3.3.18.1 Atherectomy Devices
      • 3.3.18.2 Introducer Sheaths
      • 3.3.18.3 PTA Balloon Catheters
      • 3.3.18.4 Peripheral IVUS Catheters
      • 3.3.18.5 Stent Grafts
      • 3.3.18.6 Vascular Closure Devices (VCD)
  • 3.4 CLINICAL TRIALS
    • 3.4.1 Abbott
      • 3.4.1.1 Peripheral Vascular Stent
      • 3.4.1.2 Other Peripheral Vascular Related Studies
    • 3.4.2 B. Braun
      • 3.4.2.1 Diagnostic and Interventional Catheters
      • 3.4.2.2 Peripheral Vascular Stent
    • 3.4.3 Boston Scientific
      • 3.4.3.1 Atherectomy Devices
      • 3.4.3.2 Drug-Coated Balloons
      • 3.4.3.3 Peripheral Vascular Stents
      • 3.4.3.4 Other Peripheral Vascular Related Studies
      • 3.4.3.5 Venous Stents
    • 3.4.4 C.R. Bard (BD)
      • 3.4.4.1 Diagnostic and Interventional Catheters
      • 3.4.4.2 Drug-Coated Balloons
      • 3.4.4.3 Venous Stents
      • 3.4.4.4 Other Peripheral Vascular Related Studies
    • 3.4.5 Cardinal Health
      • 3.4.5.1 Other Peripheral Vascular Related Studies
    • 3.4.6 Cook Medical
      • 3.4.6.1 Drug-Eluting Stents
      • 3.4.6.2 Inferior Vena Cava Filters
      • 3.4.6.3 Peripheral Vascular Stents
      • 3.4.6.4 Venous Stents
    • 3.4.7 Cordis (Cardinal Health)
      • 3.4.7.1 Peripheral Vascular Stents
    • 3.4.8 Medtronic
      • 3.4.8.1 Atherectomy Devices
      • 3.4.8.2 Drug-Coated Balloons
      • 3.4.8.3 Other Peripheral Vascular Related Studies
    • 3.4.9 Merit Medical
      • 3.4.9.1 Stent Grafts
    • 3.4.10 Philips/Spectranetics
      • 3.4.10.1 Atherectomy Devices
      • 3.4.10.2 Peripheral IVUS Catheters
      • 3.4.10.3 Spectranetics
      • 3.4.10.3.1 Drug-Coated Balloons
      • 3.4.10.3.2 Atherectomy Devices
    • 3.4.11 Shockwave Medical, Inc.
      • 3.4.11.1 Lithoplasty System
    • 3.4.12 Surmodics
      • 3.4.12.1 Drug-Coated Balloons
    • 3.4.13 Terumo
      • 3.4.13.1 Drug-Coated Balloons
      • 3.4.13.2 Peripheral Vascular Stents
    • 3.4.14 W.L. Gore
      • 3.4.14.1 Peripheral Vascular Stents
      • 3.4.14.2 Stent Grafts
      • 3.4.14.3 Expandable Balloons
    • 3.4.15 Other Companies
      • 3.4.15.1 Carotid Shunt / Endarterectomy
      • 3.4.15.2 Drug-Coated Balloons
      • 3.4.15.3 Peripheral Vascular Stents
      • 3.4.15.4 Other Peripheral Vascular Related Studies

PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

  • 4.1 INTRODUCTION
    • 4.1.1 Atherosclerosis
    • 4.1.2 Peripheral Arterial Disease (PAD)
  • 4.2 CURRENCY EXCHANGE RATE
  • 4.3 MARKET OVERVIEW
  • 4.4 TREND ANALYSIS
  • 4.5 DRIVERS AND LIMITERS
    • 4.5.1 Market Drivers
    • 4.5.2 Market Limiters
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS
  • 4.7 COMPANY PROFILES
    • 4.7.1 Abbott
    • 4.7.2 Becton Dickinson (BD)
    • 4.7.3 Boston Scientific
    • 4.7.4 Cardinal Health
      • 4.7.4.1 Cordis (Cardinal Health)
    • 4.7.5 Cook Medical
    • 4.7.6 Maquet
    • 4.7.7 Medtronic
    • 4.7.8 Teleflex
    • 4.7.9 Terumo Interventional System (TIS)
    • 4.7.10 W.L. Gore
  • 4.8 SWOT ANALYSIS
    • 4.8.1 Abbott
    • 4.8.2 B. Braun
    • 4.8.3 Boston Scientific
    • 4.8.4 BD
    • 4.8.5 Cardinal Health
    • 4.8.6 Cook Medical
    • 4.8.7 Integra Lifesciences
    • 4.8.8 Maquet
    • 4.8.9 Medtronic
    • 4.8.10 Merit Medical
    • 4.8.11 Phillips
    • 4.8.12 Teleflex
    • 4.8.13 Terumo
    • 4.8.14 W.L. Gore
  • 4.9 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 5.1 INTRODUCTION
      • 5.1.1.1 Population
      • 5.1.1.2 Median Age
      • 5.1.1.3 GDP Per Capita
      • 5.1.1.4 Price Index
  • 5.2 GERMANY
  • 5.3 FRANCE
  • 5.4 UNITED KINGDOM
  • 5.5 ITALY
  • 5.6 SPAIN
  • 5.7 BENELUX
  • 5.8 SCANDINAVIA
  • 5.9 AUSTRIA
  • 5.10 SWITZERLAND
  • 5.11 PORTUGAL

PROCEDURE NUMBERS

  • 6.1 PROCEDURES
    • 6.1.1 Total Procedures
    • 6.1.2 Bare Metal Stent Procedures
      • 6.1.2.1 Iliac Bare Metal Stent Procedures
      • 6.1.2.2 Femoral Popliteal Bare Metal Stent Procedures
      • 6.1.2.3 Infra-Popliteal Bare Metal Stent Procedures
      • 6.1.2.4 Renal Bare Metal Stent Procedures
      • 6.1.2.5 Carotid Bare Metal Stent Procedures
    • 6.1.3 Venous Stenting Procedures
    • 6.1.4 Angioplasty Procedures
    • 6.1.5 Atherectomy Procedures
    • 6.1.6 Chronic Total Occlusion Procedures
    • 6.1.7 Embolic Protection Device Procedures
    • 6.1.8 Stent Graft Procedures
      • 6.1.8.1 AAA Stent Graft Procedures
      • 6.1.8.2 TAA Stent Graft Procedures
      • 6.1.8.3 Fenestrated Stent Graft Procedures
    • 6.1.9 Surgical Graft Procedures
      • 6.1.9.1 Lower Limb Surgical Graft Procedures
      • 6.1.9.2 AV Access Surgical Graft Procedures
      • 6.1.9.3 Aorta Repair Surgical Graft Procedures
      • 6.1.9.3.1 AAA Surgical Graft Procedures
      • 6.1.9.3.2 TAA Surgical Graft Procedures
      • 6.1.9.4 Extra-Anatomical Surgical Graft Procedures
    • 6.1.10 AV Access Thrombectomy Procedures
    • 6.1.11 Inferior Vena Cava Filter Procedures
    • 6.1.12 Vascular Closure Device Procedures
      • 6.1.12.1 Total Invasive Vascular Closure Device Procedures
      • 6.1.12.1.1 Invasive Small Bore Vascular Closure Device Procedures
      • 6.1.12.1.2 Invasive Large Bore Vascular Closure Device Procedures
      • 6.1.12.2 Non-Invasive Vascular Closure Device Procedures
      • 6.1.12.3 Vascular Closure Device Procedures by Approach
      • 6.1.12.3.1 Femoral Vascular Closure Device Procedures
      • 6.1.12.3.2 Radial Vascular Closure Device Procedures
    • 6.1.13 Transcatheter Embolization Procedures
      • 6.1.13.1 Particle Embolization Procedures
      • 6.1.13.2 Coil Embolization Procedures
      • 6.1.13.3 Liquid Embolization Procedures
    • 6.1.14 Drug-Coated Balloon Procedures
    • 6.1.16 Lithotripsy Procedures
    • 6.1.17 IVUS Procedures

PERIPHERAL ARTERIAL STENT MARKET

  • 7.1 INTRODUCTION
    • 7.1.1 Off-Label Use
    • 7.1.2 Covered Stents
    • 7.1.3 Drug-Eluting Stents
    • 7.1.4 Stent Length
  • 7.2 MARKET OVERVIEW
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Total Peripheral Arterial Stent Market
    • 7.3.2 Total Bare-Metal Stent Market
      • 7.3.2.1 Bare-Metal Illiac Stent Market
      • 7.3.2.2 Bare-Metal Femoral-Popliteal Stent Market
      • 7.3.2.3 Bare-Metal Infra-Popliteal Market
      • 7.3.2.4 Bare-Metal Renal Stent Market
      • 7.3.2.5 Bare-Metal Carotid Stent Market
      • 7.3.2.6 Total Bare-Metal Stent Unit Analysis by Indication
    • 7.3.3 Covered Stent Market
    • 7.3.4 Drug-Eluting Stent Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS

PERIPHERAL VENOUS STENT MARKET

  • 8.1 INTRODUCTION
  • 8.2 MARKET ANALYSIS AND FORECAST
  • 8.3 DRIVERS AND LIMITERS
    • 8.3.1 Market Drivers
    • 8.3.2 Market Limiters
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS

PTA BALLOON CATHETER MARKET

  • 9.1 INTRODUCTION
    • 9.1.1 Types of PTA Balloon Catheters
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST
    • 9.3.1 Total PTA Balloon Catheter Market
    • 9.3.2 Standard PTA Balloon Catheter Market
    • 9.3.3 High-Pressure PTA Balloon Catheter Market
    • 9.3.4 Large PTA Balloon Catheter Market
    • 9.3.5 Small PTA Balloon Catheter Market
    • 9.3.6 Specialty PTA Balloon Catheter Market
  • 9.4 DRIVERS AND LIMITERS
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS

ATHERECTOMY DEVICE MARKET

  • 10.1 INTRODUCTION
  • 10.2 MARKET ANALYSIS AND FORECAST
  • 10.3 DRIVERS AND LIMITERS
    • 10.3.1 Market Drivers
    • 10.3.2 Market Limiters
  • 10.4 COMPETITIVE MARKET SHARE ANALYSIS

CHRONIC TOTAL OCCLUSION DEVICE MARKET

  • 11.1 INTRODUCTION
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • 11.3.1 Total Chronic Total Occlusion (CTO) Device Market
    • 11.3.2 Recanalization CTO Device Market
    • 11.3.3 Re-Entry CTO Device Market
  • 11.4 DRIVERS AND LIMITERS
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS

EMBOLIC PROTECTION DEVICE MARKET

  • 12.1 INTRODUCTION
    • 12.1.1 Protection Mechanism
      • 12.1.1.1 Filter Basket
      • 12.1.1.2 Distal Balloon Occlusion
      • 12.1.1.3 Flow Redirection
  • 12.2 MARKET ANALYSIS AND FORECAST
  • 12.3 DRIVERS AND LIMITERS
    • 12.3.1 Market Drivers
    • 12.3.2 Market Limiters
  • 12.4 COMPETITIVE MARKET SHARE ANALYSIS

STENT GRAFT MARKET

  • 13.1 INTRODUCTION
  • 13.2 MARKET OVERVIEW
  • 13.3 MARKET ANALYSIS AND FORECAST
    • 13.3.1 Total Stent Graft Market
    • 13.3.2 AAA Stent Graft Market
    • 13.3.3 TAA Stent Graft Market
    • 13.3.4 Fenestrated Stent Graft
  • 13.4 DRIVERS AND LIMITERS
    • 13.4.1 Market Drivers
    • 13.4.2 Market Limiters
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS

SURGICAL GRAFT MARKET

  • 14.1 INTRODUCTION
  • 14.2 MARKET OVERVIEW
  • 14.3 MARKET ANALYSIS AND FORECAST
    • 14.3.1 Total Surgical Graft Market
    • 14.3.2 Lower Limb Surgical Graft Market
    • 14.3.3 AV Access Surgical Graft Market
    • 14.3.4 Total Aorta Repair Surgical Graft Market
      • 14.3.4.1 AAA Surgical Graft Market
      • 14.3.4.2 TAA Surgical Graft Market
    • 14.3.5 Extra-Anatomical Surgical Graft Market
  • 14.4 DRIVERS AND LIMITERS
    • 14.4.1 Market Drivers
    • 14.4.2 Market Limiters
  • 14.5 COMPETITIVE MARKET SHARE ANALYSIS

AV ACCESS THROMBECTOMY DEVICE MARKET

  • 15.1 INTRODUCTION
    • 15.1.1 Other Peripheral Applications of Thrombectomy Devices
  • 15.2 MARKET ANALYSIS AND FORECAST
  • 15.3 DRIVERS AND LIMITERS
    • 15.3.1 Market Drivers
    • 15.3.2 Market Limiters
  • 15.4 COMPETITIVE MARKET SHARE ANALYSIS

INFERIOR VENA CAVA FILTER MARKET

  • 16.1 INTRODUCTION
  • 16.2 MARKET ANALYSIS AND FORECAST
  • 16.3 DRIVERS AND LIMITERS
    • 16.3.1 Market Drivers
    • 16.3.2 Market Limiters
  • 16.4 COMPETITIVE MARKET SHARE ANALYSIS

DIAGNOSTIC AND INTERVENTIONAL CATHETER MARKET

  • 17.1 INTRODUCTION
  • 17.2 MARKET OVERVIEW
  • 17.3 MARKET ANALYSIS AND FORECAST
    • 17.3.1 Total Diagnostic and Interventional Catheter Market
    • 17.3.2 Diagnostic Catheter Market
    • 17.3.3 Interventional Catheter Market
  • 17.4 DRIVERS AND LIMITERS
    • 17.4.1 Market Drivers
    • 17.4.2 Market Limiters
  • 17.5 COMPETITIVE MARKET SHARE ANALYSIS

STANDARD AND HYDROPHILIC GUIDEWIRE MARKET

  • 18.1 INTRODUCTION
  • 18.2 MARKET OVERVIEW
  • 18.3 MARKET ANALYSIS AND FORECAST
    • 18.3.1 Total Standard and Hydrophilic Guidewire Market
    • 18.3.2 Standard Guidewire Market
    • 18.3.3 Hydrophilic Guidewire Market
  • 18.4 DRIVERS AND LIMITERS
    • 18.4.1 Market Drivers
    • 18.4.2 Market Limiters
  • 18.5 COMPETITIVE MARKET SHARE ANALYSIS

INTRODUCER SHEATH MARKET

  • 19.1 INTRODUCTION
  • 19.2 MARKET ANALYSIS AND FORECAST
  • 19.3 DRIVERS AND LIMITERS
    • 19.3.1 Market Drivers
    • 19.3.2 Market Limiters
  • 19.4 COMPETITIVE MARKET SHARE ANALYSIS

VASCULAR CLOSURE DEVICE MARKET

  • 20.1 INTRODUCTION
  • 20.2 MARKET OVERVIEW
    • 20.2.1 Vascular Closure Device Market Overview by Device Type
    • 20.2.2 Vascular Closure Device Market Overview by Approach
  • 20.3 MARKET ANALYSIS AND FORECAST
    • 20.3.1 Total Vascular Closure Device Market
    • 20.3.2 Vascular Closure Device Market by Device Type
      • 20.3.2.1 Invasive VCD Market
      • 20.3.2.1.1 Small Bore Invasive VCD Market
      • 20.3.2.1.2 Large Bore Invasive VCD Market
      • 20.3.2.2 Non-Invasive VCD Market
    • 20.3.3 Vascular Closure Device Market by Approach
      • 20.3.3.1 Femoral VCD Market
      • 20.3.3.2 Radial VCD Market
  • 20.4 DRIVERS AND LIMITERS
    • 20.4.1 Market Drivers
    • 20.4.2 Market Limiters
  • 20.5 COMPETITIVE MARKET SHARE ANALYSIS

TRANSCATHETER EMBOLIZATION DEVICE MARKET

  • 21.1 INTRODUCTION
    • 21.1.1 Particle Embolic Devices
    • 21.1.2 Coil Embolic Devices
    • 21.1.3 Liquid Embolic Devices
  • 21.2 MARKET OVERVIEW
  • 21.3 MARKET ANALYSIS AND FORECAST
    • 21.3.1 Particle Embolic Device Market
    • 21.3.2 Coil Embolic Device Market
    • 21.3.3 Liquid Embolic Device Market
  • 21.4 DRIVERS AND LIMITERS
    • 21.4.1 Market Drivers
    • 21.4.2 Market Limiters
  • 21.5 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX I: DRUG-COATED BALLOON CATHETER MARKET

  • 22.1 MARKET ANALYSIS AND FORECAST
  • 22.2 DRIVERS AND LIMITERS
    • 22.2.1 Market Drivers
    • 22.2.2 Market Limiters

APPENDIX II: INTRAVASCULAR LITHOTRIPSY MARKET

  • 23.1 INTRODUCTION
  • 23.2 MARKET ANALYSIS AND FORECAST
  • 23.3 DRIVERS AND LIMITERS
    • 23.3.1 Market Drivers
    • 23.3.2 Market Limiters
  • 23.4 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX III: PERIPHERAL IVUS CATHETER MARKET

  • 24.1 INTRODUCTION
  • 24.2 MARKET ANALYSIS AND FORECAST
  • 24.3 DRIVERS AND LIMITERS
    • 24.3.1 Market Drivers
    • 24.3.2 Market Limiters
  • 24.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.